Glazer Capital, LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-10 5:03 pm Purchase | 2026-06-03 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Glazer Capital, LLC | 2,581,700 4.850% | 2,581,700 (New Position) | Filing |